---
document_datetime: 2025-05-05 15:25:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/mresvia-epar-all-authorised-presentations_en.pdf
document_name: mresvia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9546168
conversion_datetime: 2025-12-17 14:26:23.788043
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging                   | Content (concentration)   | Pack size              |
|------------------|-------------------|------------|--------------------------|---------------------------|---------------------------------------|---------------------------|------------------------|
| EU/1/24/1849/001 | mRESVIA           | --¹        | Dispersion for injection | Intramuscular use         | pre-filled syringe (COC) in a blister | 0.5 ml                    | 1 pre-filled syringe   |
| EU/1/24/1849/002 | mRESVIA           | --¹        | Dispersion for injection | Intramuscular use         | pre-filled syringe (COC) in a blister | 0.5 ml                    | 10 pre-filled syringes |
| EU/1/24/1849/003 | mRESVIA           | --¹        | Dispersion for injection | Intramuscular use         | pre-filled syringe (COC) in a tray    | 0.5 ml                    | 1 pre-filled syringe   |
| EU/1/24/1849/004 | mRESVIA           | --¹        | Dispersion for injection | Intramuscular use         | pre-filled syringe (COC) in a tray    | 0.5 ml                    | 10 pre-filled syringes |

--¹ One dose (0.5 mL) contains 50 micrograms of RSV mRNA (nucleoside modified) encapsulated in lipid nanoparticles.

The active substance is a single-stranded 5' capped mRNA encoding the RSV-A glycoprotein F stabilised in the prefusion conformation.